Latest News

Dr L. Patrick James: Incentives Must Be Aligned for Value-Based Care Arrangements
Incentives must be aligned between payers and providers to transition to value-based care and physicians must have the best access to information to make the right decisions in these value-based arrangements, explains L. Patrick James, MD, chief clinical officer for health plans and policy, medical affairs, for Quest Diagnostics
On Monday, June 26, 2017, the Biden Foundation announced the launch of the Biden Cancer Initiative, their new venture to continue the fight to make progress in cancer prevention, detection, treatment, and care.
Senate Majority Leader Mitch McConnell (R-Kentucky) faces the challenge of bridging the gap between conservatives who want a full Obamacare repeal and Republican members facing protests at home over losing Medicaid expansion.
Jenny Bogard Discusses the Goals of the Alliance for a Healthier Generation
The Alliance for a Healthier Generation believes in giving the youth the chance to live a healthier life and will continue to create healthier options at schools despite the current administration’s restriction reductions, claims Jenny Bogard, MPH, director of healthcare strategies at the Alliance for a Healthier Generation.
As part of its new Drug Competition Action Plan, the FDA has announced it will seek to spur innovation by allowing for accelerated approvals of generic drugs without competitors. It also published a list of drugs without approved generics that could be eligible for this expedited review process.
A newly published analysis, supported by an editorial, finds that the growing prevalence of cosmetic-related adverse events may warrant stronger regulation of these products used to alter appearance.
While treatments prescribed for people with chronic pulmonary disease (COPD) and asthma–COPD overlap syndrome (ACOS) are similar, there is a need for a clearer therapeutic approach for patients with ACOS, according to a new study.
Data from multiple studies have demonstrated the efficacy of Venclexta/Venclyxto in treating relapsed or refractory chronic lymphocytic leukemia, according to Roche.
Laura Topor Explains the Value of Real-Time Benefit Transactions
Real-time prescription benefit transactions are designed to give clinicians essential information on an individual patient’s benefits before writing a prescription, according to Laura Topor, president of Grenada Health.
Several studies looked at older diabetes drugs for possible effects on breast cancer prevention, as well as the effects of diet and alcohol use on breast cancer risk.
Scoring the Senate Healthcare Bill: Dr Patricia Salber Interviews Nathan Bays
Shortly before the Congressional Budget Office (CBO) released its score for the Senate healthcare bill, Patricia Salber, MD, MBA, of The Doctor Weighs In, and Nathan Bays, managing director at Cain Brothers, a healthcare investment bank, and policy advisor to The Health Management Academy, discussed how the Senate bill stands up to the House bill and speculation about how the CBO might score the bill.
A new study finds an association between Medicaid disenrollment in Tennessee and higher rates of late-stage breast cancer diagnoses and delays to treatment.

From the Journals

A claims data review suggests new approaches are needed for prevention, screening, diagnosis, and treatment of obesity and type 2 diabetes in the pediatric population.
Patient and treatment heterogeneity were characterized within a sample of nonadherent buprenorphine members; an improved understanding of these factors may optimize patient–treatment matching and intervention efforts.
The authors interviewed patients with access to a price transparency website. Despite a positive opinion of price shopping in theory, respondents reported barriers to doing so in reality.
Researchers who study diabetes camps have increasingly turned to the psychosocial benefits for children who gain opportunities to be around others like themselves.
The offer of free medications to low-income Medicare beneficiaries with diabetes enrolled in Part D plans has no impact on generic prescribing rates.
The chairman of the Mississippi State Senate Medicaid Committee outlines steps the state has taken to promote healthier lifestyles among children.
The gap in disease incidence among ethnic groups demands a policy response, say experts who weighed in on the SEARCH data.
An expert discusses her research on a critical period for patients with type 1 diabetes: moving from having parents make care decisions to taking control of disease management.
COPD Compendium
Dermatology Compendium
Diabetes Compendium
GI Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Rheumatoid Arthritis Compendium
Know Your News
HF Compendium
Managed Care PODCAST
Upcoming Partner Events
August 16-17, 2017
Philadelphia, PA
October 24-25, 2017
San Francisco, CA

Most Popular

AJMC Strategic Alliance